Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:23:24 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:SRNE - SORRENTO THERAPEUTICS INC - http://www.sorrentotherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SRNE - Qnot subscribed0.04+0.01666.7140.42220.0006  0.05  0.00060.0848  0.01412:45:30Mar 2715 min RT 2¢

Recent Trades - Last 10 of 22
Time ETExPriceChangeVolume
12:45:30Q0.040.0161,000
12:39:57Q0.02-0.0049,700
12:39:55Q0.02-0.0045,700
12:39:55Q0.02-0.004102,250
12:08:41Q0.016-0.00820
11:50:59Q0.02-0.004200
11:48:13Q0.02-0.004100
11:48:08Q0.02-0.004378
11:39:31Q0.040.016500
11:17:00Q0.02-0.0043

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-27 09:00U:SRNENews ReleaseScilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
2024-03-02 15:25U:SRNENews ReleaseScilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento
2023-10-07 19:28U:SRNENews ReleaseScilex Holding Company Retains Warshaw Burstein, LLP and Christian Attar Law to Investigate Potential Naked Short Selling, Short Positions, Stock Lending Program Activities and Market Manipulation of Its Stock Price
2023-10-04 13:00U:SRNENews ReleaseScilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
2023-10-03 09:00U:SRNENews ReleaseScilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
2023-09-22 11:38U:SRNENews ReleaseSorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
2023-09-21 16:05U:SRNENews ReleaseScilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.
2023-09-14 09:00U:SRNENews ReleaseScilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido ‚ ®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate t
2023-09-13 09:00U:SRNENews ReleaseScilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder
2023-09-12 09:00U:SRNENews ReleaseSorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19
2023-09-12 09:00U:SRNENews ReleaseScilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
2023-09-11 09:00U:SRNENews ReleaseScilex Holding Company Generates Record Monthly Revenue In August 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended August 2023, And Year-To-Date As Of August 31 2023, Based On Currently Avai
2023-09-07 09:00U:SRNENews ReleaseSorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
2023-08-08 09:50U:SRNENews ReleaseSorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bid
2023-07-27 09:00U:SRNENews ReleaseSorrento Issues a ¢ € œFAQ ¢ €  in Response to Large Number Of Urgent Requests from Scilex Dividend Short Holders and/or Record Holders
2023-07-21 17:53U:SRNENews Release/C O R R E C T I O N -- Sorrento Therapeutics, Inc./
2023-07-21 09:00U:SRNENews ReleaseSorrento Announces Launch of Voluntary Offering to Dividend Short Holders with Deadline to Participate by July 27, 2023
2023-07-20 09:00U:SRNENews ReleaseSorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders
2023-07-05 09:00U:SRNENews ReleaseSorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study
2023-06-26 09:00U:SRNENews ReleaseSorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19